Completed PHASE4 INTERVENTIONAL 1-arm NCT00530972

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies (PILOT-NR)

Treatment of Patients With Chronic Hepatitis C Co-infected With HIV Relapsers or Non Responders, Previous Exposed to Sub-optimal Therapies: Open, Pilot Trial

Sponsor: Hospital Carlos III, Madrid

Conditions Chronic Hepatitis C HIV Infections

Interventions Peginterferon alfa-2a plus ribavirin adjusted to body weight

Updated 6 times since 2017 Last updated: Sep 4, 2009 Started: Mar 31, 2006 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00530972, this PHASE4 trial focuses on Chronic Hepatitis C and HIV Infections and remains completed. Sponsored by Hospital Carlos III, Madrid, it has been updated 6 times since 2006, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Carlos III, Madrid

Data source: Hospital Carlos III, Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain